The STop UNhealthy Substance Use Now Program (STUN II)

The STop UNhealthy Substance Use Now Program (STUN II)


April 8th, 2026 - March 20th, 2027
2.50 AMA PRA Category 1 Credit Hours

Description

Learners need a stronger understanding of how to implement evidence-based screening and management of substance use disorders within primary care. Many clinicians are unfamiliar with the U.S. Preventive Services Task Force recommendations for universal adult screening and brief counseling, and lack knowledge of validated screening tools, brief intervention techniques, and pharmacologic treatment options such as buprenorphine and naltrexone. They also need to know how to integrate these practices efficiently into electronic health records and clinic workflows, overcome common barriers such as time constraints and stigma, and coordinate follow-up and referral processes. Strengthening this knowledge base will enable clinicians to adopt and sustain consistent, guideline-concordant care for patients with unhealthy alcohol or drug use.

In order to take the post-test, you will need to be logged into your OSU CCME account.

View Enduring Material Take Post-Test

Dates and Times

End Date: 3/20/2027

Objectives

1. Identify evidence-based recommendations for universal screening and management of unhealthy alcohol and drug use in primary care.

2. Select and administer validated screening tools such as the AUDIT-C and DAST-10 within clinical workflows.

3. Describe effective brief counseling approaches and pharmacologic treatments, including buprenorphine and naltrexone, for patients with substance use disorders.

4. Integrate screening, counseling, and referral processes into electronic health records and team-based workflows to improve implementation consistency.

5. Apply quality improvement strategies, including Plan-Do-Study-Act cycles, to monitor and enhance delivery of substance use disorder care.

6. Evaluate the impact of these practice changes on patient population outcomes, such as screening rates and rates of delivering evidence-based interventions to those with substance use disorders.

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this Enduring Material?

Please contact the Enduring Material coordinator listed below:

Sydneigh Burnell
Department: The Center for Continuing Medical Education (CCME)
Phone: (614) 293-9326
Email: sydneigh.burnell@osumc.edu